Sen. Manchin's Continued Pressure Leads to Action Against Pharmaceutical Companies on Behalf of Low-Income West Virginians
September 24, 2021
September 24, 2021
WASHINGTON, Sept. 24 -- Sen. Joe Manchin, D-West Virginia, issued the following news release:
After months of pressure from U.S. Senator Joe Manchin (D-WV), the Health Resources and Services Administration (HRSA) alerted six pharmaceutical manufacturers that due to their violations of the 340B Drug Pricing Program requirements - which continue to harm low-income West Virginians by preventing them from accessing safe and affordable medications - HRSA has contacted the Department of H . . .
After months of pressure from U.S. Senator Joe Manchin (D-WV), the Health Resources and Services Administration (HRSA) alerted six pharmaceutical manufacturers that due to their violations of the 340B Drug Pricing Program requirements - which continue to harm low-income West Virginians by preventing them from accessing safe and affordable medications - HRSA has contacted the Department of H . . .